Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 6Neoplasms 4Colorectal Neoplasms 4Stomach Neoplasms 3Glioma 2Weight Loss 1Triple Negative Breast Neoplasms 1Solid Tumor Cancer 1Solid Tumor 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Refractory Solid Tumors 1Recurrence 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Peritoneal Neoplasms 1Pancreatic cancer, adult 1Pancreatic Diseases 1Ovarian Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neuroblastoma 1Neoplasms, Cystic, Mucinous, and Serous 1Neoplasm Metastasis 1Metastatic Pancreatic Adenocarcinoma 1Mesothelioma 1Malignant Solid Neoplasm 1Head and Neck Neoplasms 1Gliosarcoma 1

Interventions

130-nm albumin-bound paclitaxel 5Oxaliplatin 4Leucovorin 4Gemcitabine 4Fluorouracil 4Carboplatin 4Albumin-Bound Paclitaxel 4Paclitaxel 3Cisplatin 3pembrolizumab 2Pemetrexed 2Cetuximab 2Bevacizumab 2tremelimumab 1napabucasin 1irinotecan sucrosofate 1durvalumab 1cc-486 1Taxes 1Irinotecan 1EC regimen 1CP protocol 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Carcinoma, Pancreatic Ductal × irinotecan sucrosofate × Clear all
NCT02231723 2023-11-18

A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

Sumitomo Pharma America, Inc.

Phase 1 Completed
139 enrolled
Gastrointestinal

Pancreatic cancer, adult, Digestive System Neoplasms, Endocrine Gland Neoplasms, Adenoma, Islet Cell, Pancreatic Diseases, Pancreatic Neoplasms, Carcinoma, Islet Cell, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡